{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:04Z","timestamp":1786119244820,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/ftd.0b013e318180c662","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T09:54:56Z","timestamp":1236246896000},"page":"434-438","source":"Crossref","is-referenced-by-count":12,"title":["Determination of Area Under the Whole Blood Concentration versus Time Curve after First Intravenous Cyclosporine Dose in Children Undergoing Hematopoietic Stem Cell Transplant: Limited Sampling Strategies"],"prefix":"10.1097","volume":"30","author":[{"given":"Cathryn","family":"Sibbald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Fred","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Lee","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.bmt.1700745","article-title":"A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.","volume":"19","author":"Ruutu","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1702524","article-title":"Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children.","volume":"26","author":"Peters","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/00007890-200205151-00003","article-title":"Patient management by Neoral C2 monitoring: an international consensus statement.","volume":"73","author":"Levy","year":"2002","journal-title":"Transplantation"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00007890-200205151-00002","article-title":"Clinical validation studies of Neoral C2 monitoring: a review.","volume":"73","author":"Nashan","year":"2002","journal-title":"Transplantation"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/00007890-199911150-00023","article-title":"The temporal profile of calcineurin inhibition by cyclosporine in vivo.","volume":"68","author":"Halloran","year":"1999","journal-title":"Transplantation"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","article-title":"Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation.","volume":"68","author":"Mahalati","year":"1999","journal-title":"Transplantation"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1034\/j.1399-3046.2003.00077.x","article-title":"Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion (NeoralTM) in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption.","volume":"7","author":"Trompeter","year":"2003","journal-title":"Pediatr Transplant"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM198807143190201","article-title":"Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.","volume":"319","author":"Yee","year":"1988","journal-title":"N Engl J Med"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1704213","article-title":"Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors.","volume":"32","author":"Martin","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/106002809402800315","article-title":"Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation.","volume":"28","author":"Ghalie","year":"1994","journal-title":"Ann Pharmacother"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/FTD.0b013e31815c12ca","article-title":"Achievement of target cyclosporine concentrations as a predictor of severe acute GvHD in children receiving cyclosporine and methotrexate prophylaxis.","volume":"29","author":"Punnett","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/pbc.20463","article-title":"Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: how much do we really know?","volume":"46","author":"Cole","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1592\/phco.2006.26.1.15","article-title":"Disposition of two oral formulations of cyclosporine in pediatric patients receiving hematopoietic stem cell transplants.","volume":"26","author":"Dupuis","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00007691-198905000-00017","article-title":"A reliable high-performance liquid chromatographic micromethod for the measurement of cyclosporine in whole blood.","volume":"11","author":"Giesbrecht","year":"1989","journal-title":"Ther Drug Monit"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance.","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1592\/phco.26.9.1232","article-title":"Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients.","volume":"26","author":"Ting","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement.","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(95)91748-9","article-title":"Comparing methods of measurement: why plotting differences against standard method is misleading.","volume":"346","author":"Bland","year":"1995","journal-title":"Lancet"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/clpt.1993.132","article-title":"Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.","volume":"54","author":"Lindholm","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/adc.75.3.208","article-title":"Gastrointestinal and nutritional sequelae of bone marrow transplantation.","volume":"75","author":"Papadopoulou","year":"1996","journal-title":"Arch Dis Child"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e318180c662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:47Z","timestamp":1786038527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200808000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e318180c662","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}